nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—NISCH—Paclitaxel—Docetaxel—ovarian cancer	0.0581	0.446	CbGdCrCtD
Naphazoline—NISCH—uterine cervix—ovarian cancer	0.0432	0.0768	CbGeAlD
Naphazoline—NISCH—decidua—ovarian cancer	0.0411	0.0732	CbGeAlD
Naphazoline—NISCH—Vincristine—Vinorelbine—ovarian cancer	0.0399	0.307	CbGdCrCtD
Naphazoline—NISCH—uterus—ovarian cancer	0.036	0.064	CbGeAlD
Naphazoline—NISCH—Vinblastine—Vinorelbine—ovarian cancer	0.0321	0.247	CbGdCrCtD
Naphazoline—NISCH—bone marrow—ovarian cancer	0.0305	0.0543	CbGeAlD
Naphazoline—NISCH—female gonad—ovarian cancer	0.0294	0.0524	CbGeAlD
Naphazoline—NISCH—vagina—ovarian cancer	0.0292	0.0521	CbGeAlD
Naphazoline—NISCH—testis—ovarian cancer	0.0261	0.0465	CbGeAlD
Naphazoline—ADRA2C—myometrium—ovarian cancer	0.0253	0.0451	CbGeAlD
Naphazoline—ADRA1A—epithelium—ovarian cancer	0.0209	0.0371	CbGeAlD
Naphazoline—ADRA2A—myometrium—ovarian cancer	0.0202	0.036	CbGeAlD
Naphazoline—ADRA2C—uterine cervix—ovarian cancer	0.0197	0.0351	CbGeAlD
Naphazoline—NISCH—lymph node—ovarian cancer	0.0189	0.0337	CbGeAlD
Naphazoline—ADRA2C—decidua—ovarian cancer	0.0188	0.0334	CbGeAlD
Naphazoline—ADRA2C—endometrium—ovarian cancer	0.0178	0.0317	CbGeAlD
Naphazoline—ADRA2C—uterus—ovarian cancer	0.0164	0.0292	CbGeAlD
Naphazoline—ADRA2A—uterine cervix—ovarian cancer	0.0157	0.028	CbGeAlD
Naphazoline—ADRA2A—decidua—ovarian cancer	0.015	0.0267	CbGeAlD
Naphazoline—ADRA2A—endometrium—ovarian cancer	0.0142	0.0253	CbGeAlD
Naphazoline—ADRA2C—female gonad—ovarian cancer	0.0134	0.0239	CbGeAlD
Naphazoline—ADRA2C—vagina—ovarian cancer	0.0134	0.0238	CbGeAlD
Naphazoline—ADRA2A—gonad—ovarian cancer	0.0132	0.0235	CbGeAlD
Naphazoline—ADRA2A—uterus—ovarian cancer	0.0131	0.0233	CbGeAlD
Naphazoline—ADRA2C—testis—ovarian cancer	0.0119	0.0212	CbGeAlD
Naphazoline—ADRA2A—female reproductive system—ovarian cancer	0.0118	0.021	CbGeAlD
Naphazoline—Keratitis—Paclitaxel—ovarian cancer	0.0112	0.0364	CcSEcCtD
Naphazoline—Redness—Paclitaxel—ovarian cancer	0.0108	0.035	CcSEcCtD
Naphazoline—ADRA2A—female gonad—ovarian cancer	0.0107	0.0191	CbGeAlD
Naphazoline—ADRA2A—vagina—ovarian cancer	0.0107	0.019	CbGeAlD
Naphazoline—Lacrimation—Docetaxel—ovarian cancer	0.0105	0.0341	CcSEcCtD
Naphazoline—Asthenia—Altretamine—ovarian cancer	0.0102	0.0332	CcSEcCtD
Naphazoline—ADRA2A—testis—ovarian cancer	0.00951	0.0169	CbGeAlD
Naphazoline—Dizziness—Altretamine—ovarian cancer	0.00944	0.0306	CcSEcCtD
Naphazoline—Redness—Docetaxel—ovarian cancer	0.00914	0.0297	CcSEcCtD
Naphazoline—ADRA2C—lymph node—ovarian cancer	0.00864	0.0154	CbGeAlD
Naphazoline—Nausea—Altretamine—ovarian cancer	0.00848	0.0275	CcSEcCtD
Naphazoline—Lacrimation increased—Paclitaxel—ovarian cancer	0.0079	0.0256	CcSEcCtD
Naphazoline—Lacrimation—Epirubicin—ovarian cancer	0.00708	0.023	CcSEcCtD
Naphazoline—ADRA2A—lymph node—ovarian cancer	0.00689	0.0123	CbGeAlD
Naphazoline—Sweating—Topotecan—ovarian cancer	0.00679	0.022	CcSEcCtD
Naphazoline—Lacrimation increased—Docetaxel—ovarian cancer	0.0067	0.0217	CcSEcCtD
Naphazoline—Lacrimation—Doxorubicin—ovarian cancer	0.00655	0.0213	CcSEcCtD
Naphazoline—Keratitis—Epirubicin—ovarian cancer	0.00642	0.0208	CcSEcCtD
Naphazoline—Redness—Epirubicin—ovarian cancer	0.00617	0.02	CcSEcCtD
Naphazoline—Keratitis—Doxorubicin—ovarian cancer	0.00594	0.0193	CcSEcCtD
Naphazoline—Eye pain—Paclitaxel—ovarian cancer	0.00586	0.019	CcSEcCtD
Naphazoline—Redness—Doxorubicin—ovarian cancer	0.00571	0.0185	CcSEcCtD
Naphazoline—Erythema—Vinorelbine—ovarian cancer	0.00473	0.0154	CcSEcCtD
Naphazoline—Discomfort—Topotecan—ovarian cancer	0.00465	0.0151	CcSEcCtD
Naphazoline—Lacrimation increased—Epirubicin—ovarian cancer	0.00452	0.0147	CcSEcCtD
Naphazoline—Hyperhidrosis—Topotecan—ovarian cancer	0.00437	0.0142	CcSEcCtD
Naphazoline—Lacrimation increased—Doxorubicin—ovarian cancer	0.00418	0.0136	CcSEcCtD
Naphazoline—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00412	0.0134	CcSEcCtD
Naphazoline—Hypertension—Vinorelbine—ovarian cancer	0.00409	0.0133	CcSEcCtD
Naphazoline—Discomfort—Vinorelbine—ovarian cancer	0.00398	0.0129	CcSEcCtD
Naphazoline—Asthenia—Chlorambucil—ovarian cancer	0.00364	0.0118	CcSEcCtD
Naphazoline—Eye disorder—Paclitaxel—ovarian cancer	0.00342	0.0111	CcSEcCtD
Naphazoline—Eye pain—Epirubicin—ovarian cancer	0.00335	0.0109	CcSEcCtD
Naphazoline—Asthenia—Topotecan—ovarian cancer	0.00324	0.0105	CcSEcCtD
Naphazoline—Erythema—Paclitaxel—ovarian cancer	0.00318	0.0103	CcSEcCtD
Naphazoline—Asthenia—Melphalan—ovarian cancer	0.00317	0.0103	CcSEcCtD
Naphazoline—Tension—Paclitaxel—ovarian cancer	0.00312	0.0101	CcSEcCtD
Naphazoline—Eye pain—Doxorubicin—ovarian cancer	0.0031	0.0101	CcSEcCtD
Naphazoline—Nervousness—Paclitaxel—ovarian cancer	0.00309	0.01	CcSEcCtD
Naphazoline—Nausea—Chlorambucil—ovarian cancer	0.00301	0.00978	CcSEcCtD
Naphazoline—Vision blurred—Paclitaxel—ovarian cancer	0.003	0.00974	CcSEcCtD
Naphazoline—Dizziness—Topotecan—ovarian cancer	0.00299	0.00969	CcSEcCtD
Naphazoline—Eye disorder—Docetaxel—ovarian cancer	0.0029	0.0094	CcSEcCtD
Naphazoline—Headache—Topotecan—ovarian cancer	0.00283	0.00918	CcSEcCtD
Naphazoline—Asthenia—Vinorelbine—ovarian cancer	0.00277	0.00899	CcSEcCtD
Naphazoline—Hypertension—Paclitaxel—ovarian cancer	0.00275	0.00892	CcSEcCtD
Naphazoline—Erythema—Docetaxel—ovarian cancer	0.0027	0.00876	CcSEcCtD
Naphazoline—Nausea—Topotecan—ovarian cancer	0.00268	0.0087	CcSEcCtD
Naphazoline—Discomfort—Paclitaxel—ovarian cancer	0.00268	0.00869	CcSEcCtD
Naphazoline—Nausea—Melphalan—ovarian cancer	0.00263	0.00852	CcSEcCtD
Naphazoline—Dizziness—Vinorelbine—ovarian cancer	0.00255	0.00829	CcSEcCtD
Naphazoline—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00251	0.00815	CcSEcCtD
Naphazoline—Headache—Vinorelbine—ovarian cancer	0.00242	0.00785	CcSEcCtD
Naphazoline—Hyperglycaemia—Epirubicin—ovarian cancer	0.00236	0.00765	CcSEcCtD
Naphazoline—Hypertension—Docetaxel—ovarian cancer	0.00233	0.00756	CcSEcCtD
Naphazoline—Drowsiness—Epirubicin—ovarian cancer	0.00233	0.00756	CcSEcCtD
Naphazoline—Somnolence—Paclitaxel—ovarian cancer	0.00231	0.0075	CcSEcCtD
Naphazoline—Nausea—Vinorelbine—ovarian cancer	0.00229	0.00745	CcSEcCtD
Naphazoline—Sweating—Epirubicin—ovarian cancer	0.00223	0.00725	CcSEcCtD
Naphazoline—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00218	0.00708	CcSEcCtD
Naphazoline—Drowsiness—Doxorubicin—ovarian cancer	0.00216	0.00699	CcSEcCtD
Naphazoline—Sweating—Doxorubicin—ovarian cancer	0.00207	0.0067	CcSEcCtD
Naphazoline—Somnolence—Docetaxel—ovarian cancer	0.00196	0.00635	CcSEcCtD
Naphazoline—Eye disorder—Epirubicin—ovarian cancer	0.00195	0.00634	CcSEcCtD
Naphazoline—Asthenia—Paclitaxel—ovarian cancer	0.00186	0.00605	CcSEcCtD
Naphazoline—Erythema—Epirubicin—ovarian cancer	0.00182	0.00591	CcSEcCtD
Naphazoline—Eye disorder—Doxorubicin—ovarian cancer	0.00181	0.00587	CcSEcCtD
Naphazoline—Tension—Epirubicin—ovarian cancer	0.00179	0.0058	CcSEcCtD
Naphazoline—Nervousness—Epirubicin—ovarian cancer	0.00177	0.00574	CcSEcCtD
Naphazoline—Dizziness—Paclitaxel—ovarian cancer	0.00172	0.00558	CcSEcCtD
Naphazoline—Vision blurred—Epirubicin—ovarian cancer	0.00172	0.00557	CcSEcCtD
Naphazoline—Erythema—Doxorubicin—ovarian cancer	0.00168	0.00547	CcSEcCtD
Naphazoline—Tension—Doxorubicin—ovarian cancer	0.00165	0.00536	CcSEcCtD
Naphazoline—Nervousness—Doxorubicin—ovarian cancer	0.00164	0.00531	CcSEcCtD
Naphazoline—Headache—Paclitaxel—ovarian cancer	0.00163	0.00528	CcSEcCtD
Naphazoline—Vision blurred—Doxorubicin—ovarian cancer	0.00159	0.00515	CcSEcCtD
Naphazoline—Asthenia—Docetaxel—ovarian cancer	0.00158	0.00513	CcSEcCtD
Naphazoline—Hypertension—Epirubicin—ovarian cancer	0.00157	0.0051	CcSEcCtD
Naphazoline—Nausea—Paclitaxel—ovarian cancer	0.00154	0.00501	CcSEcCtD
Naphazoline—Discomfort—Epirubicin—ovarian cancer	0.00153	0.00497	CcSEcCtD
Naphazoline—Dizziness—Docetaxel—ovarian cancer	0.00146	0.00473	CcSEcCtD
Naphazoline—Hypertension—Doxorubicin—ovarian cancer	0.00145	0.00472	CcSEcCtD
Naphazoline—Hyperhidrosis—Epirubicin—ovarian cancer	0.00144	0.00466	CcSEcCtD
Naphazoline—Discomfort—Doxorubicin—ovarian cancer	0.00142	0.0046	CcSEcCtD
Naphazoline—Headache—Docetaxel—ovarian cancer	0.00138	0.00448	CcSEcCtD
Naphazoline—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00133	0.00431	CcSEcCtD
Naphazoline—Somnolence—Epirubicin—ovarian cancer	0.00132	0.00429	CcSEcCtD
Naphazoline—Nausea—Docetaxel—ovarian cancer	0.00131	0.00425	CcSEcCtD
Naphazoline—Somnolence—Doxorubicin—ovarian cancer	0.00122	0.00397	CcSEcCtD
Naphazoline—Asthenia—Epirubicin—ovarian cancer	0.00107	0.00346	CcSEcCtD
Naphazoline—Asthenia—Doxorubicin—ovarian cancer	0.000986	0.0032	CcSEcCtD
Naphazoline—Dizziness—Epirubicin—ovarian cancer	0.000982	0.00319	CcSEcCtD
Naphazoline—Headache—Epirubicin—ovarian cancer	0.000931	0.00302	CcSEcCtD
Naphazoline—Dizziness—Doxorubicin—ovarian cancer	0.000909	0.00295	CcSEcCtD
Naphazoline—Nausea—Epirubicin—ovarian cancer	0.000882	0.00286	CcSEcCtD
Naphazoline—Headache—Doxorubicin—ovarian cancer	0.000861	0.00279	CcSEcCtD
Naphazoline—Nausea—Doxorubicin—ovarian cancer	0.000816	0.00265	CcSEcCtD
